Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Marie Skłodowska-Curie Action · Running

TULIP Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility

Coordinator
Karolinska Institutet, Sweden
Runs
1 January 2026 to 31 December 2029
Status
Running
EU funding
€1.8m
Total cost
—
Partners
12 organisations in 6 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101236395

What the project is doing

In the project's own words, from its summary on CORDIS.

Conception and pregnancy are both complex processes, with approximately 1 in 6 women worldwide experiencing infertility, often due to compromised uterine function, the organ designed solely for sustaining life. However, these dysfunctional uterine mechanisms remain not fully understood. Moreover, assisted reproduction technologies (ART) are employed to address infertility, with 5% of newborns in Europe conceived through ART.

Nevertheless, the use of ART still results in low pregnancy success rates, with uterine dysfunction being a significant factor. This underscores the importance of the uterus in medical research, which has previously received little attention for its pivotal role in the journey towards motherhood. The TULIP consortium focuses on emerging topics, including the interplay between glycosylation and the microbiota within the uterus in relation to fertility.

This interdisciplinary consortium comprises experts from six European countries, representing eight academic and four industry partners, and uniquely combines specialists in female reproductive medicine with researchers in glycobiology, microbiota studies, genomics, and data science. We aim to achieve a breakthrough in understanding the core biological aspects of conception, thereby fostering accurate and less invasive diagnostic methods that lead to more effective and personalised implementation of ART through pioneering tools designed to overcome poor reproductive outcomes.

This breakthrough will be achieved by engaging 33 early-stage researchers in a collaborative interdisciplinary training and research programme. The programme seeks to emphasise scientific knowledge while fostering entrepreneurial and transferable skills over the 48-month project period. Collectively, these efforts enhance diagnostic and therapeutic tools to improve reproductive success in both natural and assisted conception while reinforcing inter-sectoral and interdisciplinary collaborative networks and the R&I capacity.

Topics

Who is involved

OrganisationCityCountryRole
Karolinska InstitutetStockholmSwedenCoordinator
Celvia Cc ASTartuEstoniaParticipant
Tartu UlikoolTartuEstoniaParticipant
Panepistimio KritisRethimnoGreeceParticipant
Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad ValencianaValenciaSpainParticipant
Instituto Avantia De Fertilidad SLGranadaSpainAssociatedpartner
Ivi Valencia SLValenciaSpainParticipant
Universidad De GranadaGranadaSpainParticipant
National Institute for Bioprocessing Research and Training LimitedBlackrock DublinIrelandParticipant
National University of Ireland MaynoothMaynoothIrelandParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Universiteit MaastrichtMaastrichtNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI